So more good DEP® Cabazitaxel results but no one wants to license it yet .... even after two years of commercial in confidence discussions ?
2023
2021
Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $19.07K | 181.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 348460 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 58071 | 5 |
View Market Depth
| Last trade - 11.41am 18/07/2025 (20 minute delay) ? |
| SPL (ASX) Chart |